Member Info for Investinvalue

If we see a decent AUM rise in the next update SP should see a decent rise from these low levels.

Nice informative and balanced view. Thank you for taking the time to post mayflower. GL

good post

Spud news should be out. Rig has been at site 10 days. Crew mobilised and on rig. News please PMO.

RNS should be here on spud.

Um....a placing at 1.2p.

Great management and investors really doing well here? No profit going back at least 5 years. Good luck here. RNS this morning...many would have bought in on contract news now locked in with the placing at 1.2p.

Poor management and greed on display here! Cash burn way too high and a placing after releasing news locking investors in at a higher SP.

Faron Pharmaceuticals' cancer treatment gets regulatory nod for clinical trail!

http://www.msn.com/en-gb/money/finance-marketnews/oil-prices-surge-after-us-china-agree-trade-war-ceasefire/ar-BBQoPfn?ocid=ientp

It is the start of the rise back to £8. Cheer up. Maybe should have averaged down last week and could have taken this significant RNS more positively! Its great news and with YODA news also due soon this is on its way! £8

Well said. They were hoping for a lower entry price and wish they bought and topped up last week. GLA real investors in FARN.

Some have woken on the wrong side of the bed.

Always one shorter who has his face in his palm and about to miss out on one of the biggest reversals in SP. News also due on Traumakine and this as the RNS states this news is SIGNIFICANT!

Keep looking at your palm whilst the rest of us look at our profit and rise in SP!

Dr Markku Jalkanen, Chief Executive Officer of Faron, said: "Approval of our CTA to conduct a Phase I/II study with Clevegen represents a significant milestone for the Company. Clevegen, our wholly-owned novel precision cancer immunotherapy drug, has already demonstrated promising pre-clinical results and provided human ex vivo data that supported earlier pre-clinical observations. We look forward to starting recruitment into the MATINS study soon and obtaining the first in vivo surrogate marker data from Clevegen treated patients during H1-2019."

Faron Pharmaceuticals Ltd ("Faron") (LON: FARN), the clinical stage biopharmaceutical company, today announces that its Clinical Trial Application (CTA) to conduct a Phase I/II study with Clevegen, its wholly-owned novel precision cancer immunotherapy drug, in development for the treatment of selected metastatic or inoperable tumours, has been approved by the Finnish Medicines Agency (FIMEA).

84p Today with continued rise in line with oil price!

This should see a rise back to £8. News coming in is huge!

Huge step forward. Great news and well done FARON!

as a sale. Today you can buy cheaper than yesterday and what has changed apart from the oil price which is dropping? It doesn't matter as this will reverse as it always does and the decision to buy today and even if it drops further is always a good idea.

Never be hard on yourself if you don't catch the bottom. Even Buffett cant catch the bottom on recent investments.

Shallow, so 30 days approx. ZAMA is huge!

They are ready now. Spud RNS is imminent. Crew ready.